nootkatone has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, SK; Hung, LVM; Moon, JY; Ryu, JY | 1 |
1 other study(ies) available for nootkatone and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
Topics: A549 Cells; AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Citrus paradisi; Doxorubicin; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Male; Metformin; Mice, Inbred BALB C; Mice, Nude; Polycyclic Sesquiterpenes; Proto-Oncogene Proteins p21(ras); Xenograft Model Antitumor Assays | 2019 |